Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'st 836 hydrochloride'

Search results for: 'st 836 hydrochloride'

Items 41-50 of 61

Page
per page
  1. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  2. Tropisetron Hydrochloride
    B2258 Tropisetron Hydrochloride
    Target: 5-HT3 Receptors
    Summary: 5-HT3 receptor antagonist
      ≥28.4 mg/mL
  3. AEBSF.HCl
    A2573 AEBSF.HCl
     1 Citation
    Target: Serine Proteases
    Summary: Serine protease inhibitor
      ≥12 mg/mL
  4. Berberine
    N1368 Berberine
      insoluble in H2O; insoluble in EtOH; ≥14.95 mg/mL
  5. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  6. SRT1720 HCl
    A4180 SRT1720 HCl
     3 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator
      ≥25.3 mg/mL
  7. Thiamine HCl (Vitamin B1)
    B1852 Thiamine HCl (Vitamin B1)
    Summary: hydrochloride salt form of thiamine
      insoluble in EtOH; ≥10.9 mg/mL
  8. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  9. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  10. Tizanidine HCl
    B1368 Tizanidine HCl
    Summary: α2-adrenergic receptor agonist
      ≥14.51 mg/mL

Items 41-50 of 61

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 56item
  2. Natural Products 2item
  3. Lab Reagents 2item
Specificity
  1. Selective 35item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 1 item
  4. PI3K 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. mTOR 1 item
  9. Thymidine Phosphorylases 1 item
  10. GSK-3 1 item
  11. VEGFR 1 item
  12. PDGFR 1 item
  13. c-Kit 1 item
  14. Phosphodiesterases (PDEs) 2item
  15. p38 1 item
  16. GABAB Receptors 1 item
  17. Sir2-like Family Deacetylases (Sirtuins) 1 item
  18. Aminopeptidases 1 item
  19. EGFR 2item
  20. FAK 1 item
  21. Syk 1 item
  22. DNA-PK 1 item
  23. HSP90 1 item
  24. AMPK 1 item
  25. Topoisomerases 1 item
  26. Serine Proteases 1 item
  27. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  28. Pyk2 1 item
  29. 5-HT2 Receptors 2item
  30. ALK 1 item
  31. Myosin light chain kinases (MLCKs) 1 item
  32. 5-HT3 Receptors 2item
  33. Angiotensin-Converting Enzymes (ACEs) 1 item
  34. Squalene epoxidases 3item
  35. Nampt 1 item
  36. Glutamate (Metabotropic) Group I Receptors 1 item
  37. Histamine H1 Receptors 1 item
  38. Sigma Receptors 1 item
  39. AChE 1 item
  40. Inward Rectifier Potassium (Kir) Channels 1 item
  41. c-RET 1 item
  42. guanylyl cyclase 1 item
  43. dopamine receptor 1 item
  44. 5-HT1 Receptor 2item
  45. 5-HT2 Receptor 1 item
  46. NMPRTase 1 item
  47. IKK 1 item
  48. Antibiotic 1 item
  49. Calcium-Sensing Receptors (CaSRs) 2item
  50. TRPC channel 1 item
  51. GABAA receptor 1 item
  52. CRF1 Receptors 1 item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 3item
  5. Cancer 18item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 2item
  8. Colorectal Cancer 2item
  9. Erectile Dysfunction 1 item
  10. Glioblastoma 2item
  11. Glioma 2item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Lung Cancer 2item
  15. Multidrug Resistance Studies 1 item
  16. Multiple Myeloma 2item
  17. Narcolepsy 1 item
  18. Non-small Cell Lung Cancer 1 item
  19. Pancreatic Cancer 2item
  20. Prostate Cancer 3item
  21. Schizophrenia 1 item
  22. Type 2 Diabetes 1 item